CellWell record HH-47162
Mood Stabilizers in Hemodialysis: Lithium, Valproate, and Lamotrigine Dosing
Siobhan Gee
2026
In plain language
This clinical guidance for hemodialysis patients recommends targeting lower pre-dialysis lithium levels, dosing valproate after dialysis, and standard lamotrigine dosing, without reporting original trial data or outcomes.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-47162
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.